Global Action in Healthcare Network (GAIHN) - Antimicrobial Resistance, India, Enhanced infection control and prevention driven by targeted surveillance - GAIH

S Centers for Disease Control and Prevention0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年11月21日

试验速览

暂无简介。

•Component 1 (passive surveillance)
•Passive surveillance will occur for cultures sent from designated wards. All GN isolates found to be CRO by local standard of care AST may be included.
•Component 2 (active surveillance)
•Patients will be considered for inclusion in active surveillance who are identified as part of a contact investigation for an index case of a critical CRO or possible nosocomial transmission event or are admitted to a ward designated for universal active surveillance.
•Component 3 (case investigation):Patients who have an isolate that is a critical CRO (rare or novel resistance mechanism or resistance to treatment) or identified as being part of possible nosocomial transmission will be included. Inpatient contacts identified through case investigation will be included.
•Component 4 (enhanced IPC)
•Individual patients will not be included in enhanced IPC. Wards selected for enhanced IPC will include ICUs and wards where critical CRO detection or nosocomial transmission is occurring.

发起方

S Centers for Disease Control and Prevention